Asset Purchase Agreement - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Oct. 07, 2024	Dec. 31, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Common stock, issued		1,316,989	1,084,509
Series A Non Voting Convertible Preferred Stock
Business Acquisition [Line Items]
Number of preferred stock converted into common stock	1,000
Bridge Medicines
Business Acquisition [Line Items]
Common stock, issued	62,594
Preferred stock, issued	160.562
Total cost of asset purchase	$ 4,400	$ 4,395
Bridge Medicines | Series A Non Voting Convertible Preferred Stock
Business Acquisition [Line Items]
Preferred stock, issued	160.562
Preferred stock, par value	$ 0.00001